Alltracel reports positive tests

FLEDGLING pharmaceutical company Alltracel has reported positive news from tests of its m-doc product as a cholesterol-reducing agent in food.

The firm, which is quoted on London’s Alternative Investment Market, said there were no adverse effects arising from initial patient tests.

Most patients saw a reduction in their cholesterol levels, boosting hopes the firm will be able to develop a new revenue stream to go hand-in-hand with its first-aid products.